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INTRODUTION
Primary penile sarcoma is an extremely rare condition. 
The incidence of penile sarcoma is described as 0.6 to 
1 out of 100,000 patients in developed countries, and 
leiomyosarcoma is the predominant histological type.1 Given 
such a low incidence, treatment for this condition is very 
controversial. The authors could not find in the literature any 
other case of penile sarcoma with such histological findings 
(Pleomorphic undifferentiated sarcoma). 
CASE REPORT
J.M. is a 78 year-old male who was experiencing 
discomfort and pain in the perineal region for one month. 
Physical examination revealed a 5 centimeter perineal nodule 
right below the scrotum. The ultrasound examination showed 
a solid mass with intense vascularization arising from the 
corpora cavernosa, while the MRI showed no evidence of 
invasion into adjacent structures (Figure 1). Core biopsy of 
the lesion revealed a pleomorphic undifferentiated sarcoma 
originating from the corpora cavernosa. Abdominal and 
chest work-ups were negative. The patient was submitted to 
neoadjuvant chemotherapy with Doxorubicin (25 mg/m2/day) 
and Iphosphamide (1.7mg/m2/day) from D1 to D3, followed 
by intensity-modulated radiotherapy (total dose of 66 Gy) 
of the pelvic area, lymph nodes, and the base of the corpora 
cavernosa. The result demonstrated good response and partial 
regression of the mass. The patient was then submitted to 
total penectomy, as well as intraoperatory radiation at a 
dose of 6 MeV of electrons and 10 Gy, with a 51 mm cone. 
Figure 1A - MRI. The arrow shows deep infiltration into the corpora caver-
nosa. 1B- Total penectomy specimen showing extensive penile infiltration
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Histopathological findings revealed a pleomorphic, high-
grade sarcoma and negative margins upon resection (Figure 
2A). All immunohistochemical panels were negative (Figure 
2B). Four months later, the patient presented inguinal pain 
and a CT scan showed a lymph node mass of 2.4 cm. The 
mass was promptly removed, revealing the presence of an 
undifferentiated sarcoma invading the adjacent fat tissue. 
The patient received an extra course of chemotherapy 
consisting of Taxotere at 36 mg/m2 and Gencitabine at 800 
Figure 2A - Undifferentiated Pleomorphic Sarcoma of the penis (HE, 
X100). B- Immunohistochemical panels, negative for all tested antibodies 
(CD117- CKit, HHF35, Desmin, CD34-KBEND10, CD31- JC70A, F100 
protein, AE1AE3, EMA and CD20, 45, 30)
mg/m2 from D1-D8. Systemic progression occurred during 
the chemotherapy, with the appearance of pulmonary 
and hepatic nodules. The patient was then administered 
Thalidomide with no response, and died from the disease 17 
months after the initial diagnosis. 
DISCUSSION 
Primary sarcoma of the penis is a very rare condition, 
and to date there are only around 44 cases described in the 
medical literature, of which 30 are leiomyosarcomas and 
14 are epithelial sarcomas.2 Different types of sarcomas 
are even rarer and, after extensive literature searches, we 
were unable to find any other cases of primary pleomorphic 
undifferentiated sarcoma of the penis. One possible 
explanation for these histological findings could be the 
occurrence, at some point, of a de-differentiation. On the 
other hand, the tumor could have been pleomorphic from 
the start.3 
The therapeutic approach to such cases is very 
challenging and remains controversial. We do know 
that these lesions originate from the base of the corpora 
cavernosa and are usually treated by total penectomy with or 
without associated radiation and chemotherapy.3 Regardless 
of the therapeutic modality used, the majority of patients 
die in less than two years due to systemic dissemination3. 
The most appropriate approach to treating such conditions 
remains to be determined.
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